The ABPI has appointed Christine Rowland to the newly created position of Value & Access Manager in the association’s Commercial Department.
Christine will be working on a range of projects to improve patient access to innovative medicines in line with the ABPI’s strategic objectives around Health Technology Assessment and market access.
Christine joined the ABPI from Pfizer where she worked for the past 12 years in a range of roles including sales, marketing, HTA and market access, and in areas including oncology and rare diseases. She worked in the pharmaceutical industry for more than 17 years, and prior to this for ten years as a qualified nurse and midwife in the NHS.
Commenting on her appointment, Christine said:
“I am delighted to join the ABPI at this time of great change in the landscape of the UK health system and the NHS. I look forward to working with colleagues both within the ABPI and externally to ensure that patients have access to the latest innovative medicines they require and working to ensure the full implementation of the new PPRS agreement.”
Commenting on Christine’s appointment, ABPI Director of Value and Access Paul Catchpole said:
“There are an increasing number of commercial initiatives that the ABPI is leading on. These include the implementation of the new PPRS scheme, working with NICE on value based assessment and helping our members with the changing NHS landscape whilst continuing to push for greater use of newer medicines. Christine is a very welcome addition to the team”.
About the ABPIThe ABPI represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.
Our industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. Our members supply 90 per cent of all medicines used by the NHS, and are researching and developing over two-thirds of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome diseases.
The ABPI is recognised by government as the industry body negotiating on behalf of the branded pharmaceutical industry, for statutory consultation requirements including the pricing scheme for medicines in the UK.
Media enquiriesABPI Press OfficeTelephone: +44 (0) 20 7747 1410 or +44 (0) 20 7747 1441Mobile: +44 (0) 7850 312064 or +44 (0) 7808 641811Email: firstname.lastname@example.org